Correlation Between Mustang Bio and ProMIS Neurosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mustang Bio and ProMIS Neurosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mustang Bio and ProMIS Neurosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mustang Bio and ProMIS Neurosciences, you can compare the effects of market volatilities on Mustang Bio and ProMIS Neurosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mustang Bio with a short position of ProMIS Neurosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mustang Bio and ProMIS Neurosciences.

Diversification Opportunities for Mustang Bio and ProMIS Neurosciences

MustangProMISDiversified AwayMustangProMISDiversified Away100%
0.58
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Mustang and ProMIS is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Mustang Bio and ProMIS Neurosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProMIS Neurosciences and Mustang Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mustang Bio are associated (or correlated) with ProMIS Neurosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProMIS Neurosciences has no effect on the direction of Mustang Bio i.e., Mustang Bio and ProMIS Neurosciences go up and down completely randomly.

Pair Corralation between Mustang Bio and ProMIS Neurosciences

Given the investment horizon of 90 days Mustang Bio is expected to under-perform the ProMIS Neurosciences. In addition to that, Mustang Bio is 2.71 times more volatile than ProMIS Neurosciences. It trades about -0.01 of its total potential returns per unit of risk. ProMIS Neurosciences is currently generating about -0.01 per unit of volatility. If you would invest  477.00  in ProMIS Neurosciences on December 2, 2024 and sell it today you would lose (406.00) from holding ProMIS Neurosciences or give up 85.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Mustang Bio  vs.  ProMIS Neurosciences

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -60-40-20020
JavaScript chart by amCharts 3.21.15MBIO PMN
       Timeline  
Mustang Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Mustang Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15JanFebFebMar2.55101520
ProMIS Neurosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ProMIS Neurosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15JanFebFebMar0.70.80.911.1

Mustang Bio and ProMIS Neurosciences Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-15.7-11.76-7.82-3.88-0.05213.076.29.3312.45 0.0050.0100.0150.0200.025
JavaScript chart by amCharts 3.21.15MBIO PMN
       Returns  

Pair Trading with Mustang Bio and ProMIS Neurosciences

The main advantage of trading using opposite Mustang Bio and ProMIS Neurosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mustang Bio position performs unexpectedly, ProMIS Neurosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProMIS Neurosciences will offset losses from the drop in ProMIS Neurosciences' long position.
The idea behind Mustang Bio and ProMIS Neurosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories